Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Outotec warns about possible material additional costs related to a large project

OUTOTEC OYJ STOCK EXCHANGE RELEASE   OCTOBER 26, 2018 at 9:00 AM Outotec warns about possible material additional costs related to a large project Outotec has delivered a first-of-its-kind ilmenite smelter, with two large alternating current (AC) electric furnaces, as part of a greenfield plant delivery signed in 2012. Both furnaces had their challenges during the original start-ups in 2015 and 2016. Furnace 1 was repaired and rebuilt, but during the ongoing start-up of the repaired furnace, there were problems and the start-up operation was terminated. Investigation of the furnace

MSAB: Need for decentralized solutions on the rise

MSAB: Need for decentralized solutions on the rise January - September · Net sales increased 0.4 percent to SEK 217.7 (216.9) million (-2 percent in local currencies). · EBIT for the year amounted to SEK 24.0 (51.9) million. · The EBIT margin reached 11.0 (23.9) percent. · Profit after tax amounted to SEK 20.4 (38.8) million. · Earnings per share were SEK 1.10 (2.12). · Cash flow from operating activities amounted to SEK -23.7 (-2.7) million. · Cash and cash equivalents and short-term investments amounted to SEK 70.5 (76.3) million at the end of the period.

Dates for SSAB’s financial reports in 2019

Dates for SSAB’s financial reports in 2019 and the AGM.January 29, 2019               Financial statement release (year-end report) for 2018 April 25, 2019                     Q1 – Interim report for January-March 2019 July 19, 2019                      Q2 –Interim report for January-June 2019 October 23, 2019                Q3 – Interim report for January-September 2019 Reports are published at 7.30am CET/CEST on the release date unless otherwise announced. The Annual Report 2018 will be published in week 12. The Annual General Meeting 2019 will be held in Stockholm on

CEO and President Magnus Welander comments on the Thule Group (publ) Interim Report for the third quarter, July-September, 2018

A stable quarter with major launch effortsThird quarter sales rose to SEK 1,561m (1,385), up 12.7 percent (3.8 percent after currency adjustment). Accordingly, sales increased SEK 461m (up 5.6 percent after currency adjustment) in the first three quarters of the year. During the quarter EBIT increased 3.4 percent and for the first three quarters operating income has grown by SEK 97m (up 9.6 percent).The third quarter was dominated by major launches for the future which led to increased development and launch costs of approx. SEK 25m year-on-year.Thule’s longstanding market leading

Nomination Committee for Volati AB’s 2019 Annual General Meeting

Volati AB’s Nomination Committee for the 2019 Annual General Meeting has been appointed. The Nomination Committee is composed of the following members:  - Carin Wahlén (Nomination Committee Chairman) representing the Chairman of the Board Patrik Wahlén  - Karl Perlhagen representing himself  - Jannis Kitsakis representing the Fourth Swedish National Pension Fund  The Nomination Committee for the 2019 AGM is therefore the same as for the 2018 AGM, apart from the fact that the Fourth Swedish National Pension Fund is now represented on the Committee as the third-largest shareholder.

Thule Group (publ) – Interim report for the third quarter, July-September 2018

· Net sales for the third quarter amounted to SEK 1,561m (1,385), corresponding to an increase of 12.7 percent. Adjusted for exchange rate fluctuations, sales rose 3.8 percent. · Operating income totaled SEK 267m (258), corresponding to an increase of 3.4 percent and a margin of 17.1 percent (18.6). Adjusted for exchange rate fluctuations, operating income decreased 3.0 percent. · Net income was SEK 189m (185). · Cash flow from operating activities totaled SEK 499m (519). · Earnings per share before dilution amounted to SEK 1.83 (1.81). The full report is available at

Redeye: Acconeer should still be on your radar (updated post-Q3 version)

This is an updated version of our initiating coverage report from last week. We have made negligible revisions in our 2018 estimates related to short-term cost assumptions where we now expect an EBIT of SEK -35m (-39m) for 2018. Other than that the rest of the initial report, our estimates, valuation and investment case etc. are exactly the same and just as relevant as the first version. Download the research update: http://bit.ly/2RdAdU7  Start following companies at Redeye to recieve the latest research withtin Life Science and Technology. This is a press release from Redeye -

SSAB to invest in increased Q&T steel production capacity

SSAB is to invest a total of around SEK 1 billion in SSAB Americas’ steel mill in Mobile, Alabama to increase production capacity for quenched and tempered (Q&T) steels and to reduce costs. The investments will take place during 2019-2021 and will increase the annual capacity of Q&T in Mobile from 300,000 tonnes to 400,000 tonnes. Taking into account the cost savings, the payback time is estimated to be less than four years.“SSAB is a global leader in Q&T steels and we have largely driven market growth through application development together with customers. Over the past 20 years, we have

Redeye: Formpipe - Solid Q3 as expected – SaaS migration taking a break

In total, Formpipe’s Q3 report was solid and in line with our expectations. Our key takeaway from this report is the fact that Microsoft Dynamics’ migration to SaaS inflated the ACV levels in H2 2017. The lowered SaaS estimates are, however, neutralized by increased forecasts for S&M and on-premises sales. We do not make any major adjustments to our estimates, and we keep our Base case at SEK 17. Read more in the Research Update by Johan Svantesson: http://bit.ly/2OMZDuW  Start following companies at Redeye to instantly receive our latest equity research. This is a press release

Kindred Group plc - Interim report January – September 2018 (unaudited)

Third quarter and the period January to September highlights · Gross winnings revenue amounted to GBP 230.7 (193.6) million for the third quarter of 2018, an increase of 19 per cent, and GBP 657.5 (513.4) million for the period January to September 2018. · Underlying EBITDA for the third quarter of 2018 was GBP 55.7 (46.8) million, and GBP 144.9 (110.5) million for the period January to September 2018. · Strong cash flows of GBP 57.1 (47.7) million generated from operating activities before movements in working capital in the third quarter 2018 and GBP 148.6 (109.1) million for the

Ahlsell Q3 2018: The Ahlsell model delivers and brings record sales

Third quarter 2018 · Net sales increased by 15% to MSEK 7,458 (6,492). Organic growth was 7% (10). · Operating profit (EBIT) was MSEK 524 (510). · Profit (EBITA) amounted to MSEK 620 (597), with an EBITA margin of 8.3% (9.2). EBITA includes items affecting comparability of MSEK -30. Adjusted EBITA increased by 9% to MSEK 650 (597), with an adjusted EBITA margin of 8.7% (9.2). · Profit after tax increased by 14% to MSEK 367 (323). · Diluted earnings per share amounted to SEK 0.86 (0.74). · Cost-saving measures have been intensified during the quarter. These measures are,

XVIVO Perfusion AB (publ) Interim Report January – September 2018

GOOD SALES GROWTH DRIVEN BY WARM PERFUSIONTHIRD QUARTER 2018 (JUL - SEP) • Total net sales in the quarter amounted to SEK 40.9 (32.3) million, corresponding to an increase of 27 percent. The increase corresponds to 18 percent in local currency. Net sales of non-durable goods in the quarter amounted to SEK 40.3 (31.6) million, corresponding to an increase of 27 percent in SEK. Sales of non-durable goods increased by 18 percent in local currency.• Sales from warm perfusion* showed a growth record of more than 60 percent during the quarter. Sales from warm perfusion represented 40 percent

Report for the third quarter of 2018: SSAB Americas leads the continued earnings improvement

The quarter · Sales were SEK 19,038 (16,188) million · Operating profit before depreciation/amortization and items affecting comparability was SEK 2,563 (2,016) million  · Operating profit, excluding items affecting comparability, was SEK 1,600 (1,089) million · Operating profit, including items affecting comparability of SEK -213 million, was SEK 1,387 (1,089) million · Earnings per share were SEK 0.85 (0.56) · Operating cash flow was SEK 1,922 (1,590) million · Net debt/equity ratio was 17% (27%)Comments by the CEO SSAB’s operating profit, excluding items

Catella divests Wealth Management operations in Luxembourg to VP Bank

Catella Bank S.A., a fully owned subsidiary of Catella AB (publ), has entered an asset transfer-agreement to divest its Wealth Management operations in Luxembourg to VP Bank (Luxembourg) SA as part of the previously announced strategic review, for approximately SEK 110 Million.The Swedish Wealth Management division and the Card Issuing-operations is not part of this transaction and the strategic review is ongoing with regards to these two operations. As previously announced Catella aim to exit the consolidated situation due to the extensive regulatory framework and inefficient capital-

Stockmann Group’s Interim Report 1 January - 30 September 2018

The Group’s adjusted operating result back to profit in Q3STOCKMANN plc, Stock Exchange Release 26.10.2018 at 8:00 EET July-September 2018, continuing operations:- Consolidated revenue was EUR 232.5 million (242.0), up 0.3% in comparable currency rates.- Gross margin was 58.7% (56.2).- Adjusted operating result was EUR 5.9 million (-1.4).- Reported operating result was EUR -4.9 million (-151.4), including a value adjustment of EUR -10.8 million related to Nevsky Centre. January-September 2018, continuing operations:- Consolidated revenue was EUR 714.3 million (740.1).-

The Swedish harvest – an updated forecast from Lantmännen

The harvest has been completed in Sweden and Lantmännen can now present an updated estimate of the total Swedish harvest of grain, oilseed crops and pulses.The extreme weather this summer has had a clear impact on Swedish agriculture. Now when the harvest of grain, oilseed crops and pulses has been brought in across the whole country, Lantmännen can report that the end results are lower than the earlier estimate of 4.2 million tons. Lantmännen now puts the combined harvest in Sweden at 3.5 million tons – compared with the five-year average of 6.2 million tons, in other words, about half the

Read original

Invitation to the presentation of Catena Media´s interim report January – September 2018

Catena Media´s interim report for January – September 2018 will be published Tuesday 6 November at 07.00 CET.A combined telephone conference with the opportunity to ask questions will be held at 09.00 CET on the same day, with CEO Per Hellberg and CFO Pia-Lena Olofsson presenting the report. The telephone conference will end with the opportunity to pose specific questions to US General Manager Michael Daly regarding developments in the US. The presentation will also be simultaneously webcasted here . The presentation will be held at

Tenants first

D. Carnegie & Co AB (publ) reports for the third quarter of 2018 an increased profit after tax amounting to SEK 881 million compared to SEK 525 million for the third quarter of the previous year. For the first nine months of the year, profit after tax amounted to SEK 2,709 million compared with SEK 1,229 million corresponding period previous year. Earnings per share after tax were SEK 30.97 (15.86). The adjusted equity (EPRA NAV) increased 30 percent compared to the third quarter 2017 and amounted to SEK 158.13 per share (122.04) as of 30 September 2018.January – September 2018 •

Nordic Nanovector Announces Opening of First US Site for PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma

Oslo, Norway, 26 October 2018 Nordic Nanovector ASA (OSE: NANO) announces that the first clinical site in the United States (in Long Beach, CA) for the pivotal PARADIGME trial has been initiated to enable enrolment of patients. PARADIGME is a global randomised Phase 2b clinical trial comparing two Betalutin® (177Lu-satetraxetan-lilotomab) dosing regimens (15 MBq/kg Betalutin® following 40mg lilotomab pre-dosing; 20 MBq/kg Betalutin® following 100mg/m2 lilotomab pre-dosing) in 3L follicular lymphoma patients who are refractory to anti-CD20 therapy (including rituximab). The trial aims

Interim report January - September 2018

Third solid Quarter in a row· Consolidated net revenues for the third quarter of 2018 increased to SEK 3,180 M (2,986). · Operating earnings excluding non-recurring items, items affecting comparability and revaluations (“EBIT adjusted”) increased to SEK 1,095 M (999). · Net Debt / Cash EBITDA decreased to 3.8 (3.9) · The carrying values of portfolio investments have decreased marginally since the end of the preceding quarter. Portfolio investments for the quarter amounted to SEK 927 M (1,177).The return on portfolio investments was 14 percent (15). · In Credit

A new industry player: Blue World Technologies aims to be a synonym with the future of sustainable mobility by making fuel cells in a simple way

The ban of diesel and gasoline cars is just around the corner, but how can we supplement battery electric cars while maintaining the advantages of a liquid fuel and at the same time make it fossil free and clean? Blue World Technologies has been founded with the purpose of developing and manufacturing methanol fuel cell system for the mobility business. Methanol fuel cells have zero harmful emissions and use a simple liquid and renewable fuel. Blue World is located in Aalborg, Denmark, with a global outlook with sight on regions and markets with real change in mind.  The

Historic quarter for Moelven

Moelven delivered a solid result in the third quarter, which was marked by a world record and its biggest-ever investment.Moelven Industrier ASA achieved operating revenues of NOK 129.6 million in the third quarter of 2018. This is an increase of NOK 91.4 million compared to the same period last year. Revenue in Q3 totalled NOK 2,494 million (against NOK 2,440.6 million in 2017).  “Moelven is affected by the activity in the global economy. A growing international focus and higher prices for wood products for industrial use are yielding good results for our Timber division. Construction in

Xspray Pharma prepares for listing on main list

STOCKHOLM, SWEDEN – October 25, 2018. Xspray Pharma (Nasdaq First North: XSPRAY) today announced the decision of the company's board of directors that Xspray will apply for listing of the company's share on Nasdaq Stockholm's main list. The list change is expected to take place within 12 months and is made to improve the prerequisites for a broader ownership base.The company's board and management will now initiate the work required to prepare the company for listing on the main list. The goal is to complete the up-listing within the next twelve months. "We feel that Xspray is mature for

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

The shareholders of Xspray Pharma AB (publ), reg. no. 556649-3671 are hereby summoned to attend the extraordinary general meeting ("EGM") on Wednesday 28 November 2018 at 10.00 a.m. CET at Advokatfirman Cederquist’s premises on Hovslagargatan 3 in Stockholm, Sweden.Right to participate Those who have been recorded as shareholders in the share register kept by Euroclear Sweden AB as per Thursday 22 November 2018, and who no later than on Thursday 22 November 2018, have given notice to the company of their intent to participate at the EGM, shall have the right to participate at the EGM.

There are no items matching the current filter
There are no more items matching the current filter
Back to top